Teva in talks to buy Allergan big generic-drug unit: WSJ

(Reuters) – Israeli drug maker Teva Pharmaceutical Industries Ltd is in talks to combine with Allergan Plc’s big generic-drug business, the Wall Street Journal reported on Saturday, citing people familiar with the matter.